Taipei, Wednesday, April 16, 2014 19:29 (GMT+8)
mostly cloudy
Taipei
26°C
Taiwan PCB makers ramping up capacity - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Monday 19 November 2012]
  • Apex Biotechnology
  • Performance
    The company's stock price closed at NT$67.3 on the TSE on Tuesday, April 15, 2014.
    The company has reported consolidated revenues of NT$138 million for March 2014, representing a 9.7% increase on month and 25.6% drop on year.
    For the fourth quarter of 2013, the company totaled NT$354 million in consolidated revenues, down 22% sequentially and down 26.5% on year.
    Brief

    Full name: Apex Biotechnology

    Chinese name: 五鼎生物技術股份有限公司

    Short name: Apex

    Stock code: 1733

    Tax ID: 16130182

    Market: TSE

    Established: 2 Dec 1997

    Paid in capital: NT$985.31 million

    Listed on TSE: 17 Sep 2001

    Website: www.apexbio.com

  • Latest stock
    Apex [1733] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    16-Apr 122 109 8,220,965 67.30 67.80 67.20 67.80+0.50+0.74% 67.80 67.50
    15-Apr 59 66 3,988,549 67.10 67.50 67.10 67.30+0.30+0.45% 67.30 67.20
    14-Apr 180 144 12,065,872 67.30 67.40 66.80 67.00-0.30-0.45% 67.10 67.00
    11-Apr 202 175 13,610,786 67.50 67.80 67.30 67.30-0.60-0.88% 67.60 67.30
    10-Apr 183 152 12,416,676 68.00 68.20 67.60 67.90-0.30-0.44% 68.00 67.80
    9-Apr 143 108 9,716,376 67.80 68.20 67.70 68.20+0.30+0.44% 68.30 68.20
    8-Apr 167 98 11,338,091 68.00 68.50 67.70 67.90-0.10-0.15% 68.10 67.90
    7-Apr 73 78 4,980,948 67.90 68.10 67.70 68.00+0.10+0.15% 68.10 68.00
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Mar 2013 - Mar 2014 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Mar-14

    138

    9.7%

    (25.6%)

    423

    (19.2%)

    Feb-14

    126

    (20.7%)

    (20.4%)

    285

    (15.7%)

    Jan-14

    159

    26.5%

    (11.6%)

    159

    (11.6%)

    Dec-13

    126

    9.8%

    (20.5%)

    1,829

    (9.7%)

    Nov-13

    114

    (0%)

    (27.8%)

    1,704

    (8.8%)

    Oct-13

    114

    (25.9%)

    (30.9%)

    1,589

    (7%)

    Sep-13

    154

    0.3%

    8.4%

    1,475

    (4.5%)

    Aug-13

    154

    5.6%

    0.2%

    1,320

    (5.8%)

    Jul-13

    146

    3%

    (8.8%)

    1,166

    (6.5%)

    Jun-13

    142

    (17.9%)

    (14.3%)

    1,021

    (6.2%)

    May-13

    173

    (5.3%)

    (6.4%)

    879

    (4.8%)

    Apr-13

    182

    (2%)

    (9.5%)

    706

    (4.4%)

    Mar-13

    186

    17.4%

    (8.8%)

    524

    (2.4%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2014

    Apex: Consolidated revenues, 4Q12 - 4Q13 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    4Q-13

    354

    (22%)

    (26.5%)

    1,829

    (9.7%)

    3Q-13

    454

    (8.5%)

    (0.4%)

    1,475

    (4.5%)

    2Q-13

    497

    (5.2%)

    (9.9%)

    1,021

    (6.2%)

    1Q-13

    524

    8.7%

    (2.4%)

    524

    (2.4%)

    4Q-12

    482

    5.7%

    (3.1%)

    2,026

    8%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2014

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 4Q12 - 4Q13 (NT$k)

    Item

    4Q-2013

    3Q-2013

    2Q-2013

    1Q-2013

    4Q-2012

    Current assets

    1,447,851

    1,347,766

    1,644,885

    1,922,635

    1,815,585

    Intangible assets

    26,174

    17,236

    17,816

    14,190

    14,554

    Non-current assets

    1,276,137

    1,341,620

    1,027,811

    967,210

    929,767

    Assets

    2,723,988

    2,689,386

    2,672,696

    2,889,845

    2,745,352

    Current liabilities

    383,354

    382,837

    416,522

    353,703

    336,313

    Non-current liabilities

    420,118

    421,334

    421,188

    419,978

    419,273

    Liabilities

    803,472

    804,171

    837,710

    773,681

    755,586

    Stockholders' equity

    1,920,516

    1,885,215

    1,834,986

    2,116,164

    1,989,766

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2014

    Apex: Consolidated income statement, 4Q12 - 4Q13 (NT$k)

    Item

    4Q-2013

    3Q-2013

    2Q-2013

    1Q-2013

    4Q-2012

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

     

     

     

     

     

     

     

     

    486,607

     

    Operating revenue

    354,410

    72.8%

    454,277

    93.4%

    496,560

    102%

    523,974

    107.7%

    481,967

    99%

    Gross profit (loss) from operations

    106,527

    21.9%

    120,929

    24.9%

    169,175

    34.8%

    171,812

    35.3%

    190,327

    39.1%

    Operating expenses

    59,426

    12.2%

    51,361

    10.6%

    56,054

    11.5%

    52,611

    10.8%

    52,896

    10.9%

    Operating income (loss)

    48,747

    10%

    67,922

    14%

    113,121

    23.2%

    119,201

    24.5%

    137,431

    28.2%

    Non-operating revenues and gains

     

     

     

     

     

     

    25,800

    5.3%

    1,866

    0.4%

    Non-operating expenses and losses

    -3,812

    -0.8%

    -8,211

    -1.7%

    0

    0%

     

     

    -6,023

    -1.2%

    Income from continuing operations before income tax

    44,935

    9.2%

    59,711

    12.3%

    176,732

    36.3%

    145,001

    29.8%

    131,412

    27%

    Net income (loss)

    30,322

    6.2%

    51,591

    10.6%

    163,005

    33.5%

    125,925

    25.9%

    125,637

    25.8%

    Diluted earnings per share (NT$)

    0.1

     

    0.5

     

    1.6

     

    1.2

     

    1.2

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2014

  • Apex Biotechnology full profile
Realtime news
  • O-Film expected to produce for 35% of handset touch panels in 2014

    Before Going to Press | 51min ago

Pause
 | 
View more

16-Apr-2014 markets closed

 LastChange

TAIEX (TSE)8923.82+7.11+0.08% 

TSE electronic340.02+0.12+0.04% 

GTSM (OTC)144.01+0.41+0.29% 

OTC electronic179.21+0.17+0.09% 

DIGITIMES Research Data Services
China touch tracker
2014 global mobile application processor market forecast
  • Trends in the upstream LED equipment and materials industries, 2H13

    This report examines the outlook for upstream, which includes MOCVD equipment, rare earth materials and sapphire substrates, is also particularly significant as an indicator of trends in the LED industry as a whole over the next year.

  • TD-LTE market developments and forecast, 2014-2016

    TD-LTE has become the mainstream global choice for the construction of 4G asymmetric frequency spectrum networks. This Digitimes Research Special Report examines the current global status of TD-LTE, and forecasts developments in the TD-LTE supply chain in China and worldwide through 2016.